| #402 |
Derek Charles Lietz |
Aon Risk Services, Inc. Of Maryland |
1 |
| #402 |
Benjamin Wiley |
Duke University |
1 |
| #402 |
Michael S. Farid |
— |
1 |
| #402 |
Elizabeth Clark-Polner |
Symbotic |
1 |
| #402 |
Vic Odryna |
Layer3 Tv |
1 |
| #402 |
Kennan G. Arlen |
— |
1 |
| #402 |
Charles Joseph Vadala, Jr. |
Heartware |
1 |
| #402 |
Samuel D. Stimple |
Novo Nordisk A/S |
1 |
| #402 |
Danielle Hicks |
— |
1 |
| #402 |
Pablo Engel |
Dana-Farber Cancer Institute |
1 |
| #402 |
Braden E. Knight |
— |
1 |
| #402 |
Kathryn L. Howard |
IBM |
1 |
| #402 |
Juan Carlos Rodero Sales |
— |
1 |
| #402 |
Paul Brown |
Elektrofi |
1 |
| #402 |
Abigail June Spencer |
Draper Laboratory |
1 |
| #402 |
Adam Greenbaum |
Amazon |
1 |
| #402 |
Karen Inouye |
Harvard University |
1 |
| #402 |
Joseph Bolen |
Vor Biopharma |
1 |
| #402 |
Ennio Antonio Chiocca |
Brigham and Women's Hospital |
1 |
| #402 |
David Deininger |
Vertex Pharmaceuticals Incorporated |
1 |
| #402 |
Mengyang Li |
Nutanix |
1 |
| #402 |
Wataru Yashiro |
The General Hospital |
1 |
| #402 |
Amine Hamdi |
Acentium |
1 |
| #402 |
Thomas C. Copeman |
Nara Logics |
1 |
| #402 |
Stephen Archer |
Gen9 |
1 |
| #402 |
Alexandra Johnson |
Sigopt |
1 |
| #402 |
Benjamin Rubin |
Unknown |
1 |
| #402 |
Emily Rachel Capodilupo |
Whoop |
1 |
| #402 |
Tarek Assali |
Oracle |
1 |
| #402 |
Hadi Shafiee |
Brigham and Women's Hospital |
1 |
| #402 |
Katharyn A. Wilber |
Veeva Systems |
1 |
| #402 |
Warren Dorsch |
Vertex Pharmaceuticals Incorporated |
1 |
| #402 |
Anna Claire Maurer |
Massachusetts Eye And Ear Infirmary |
1 |
| #402 |
Natasja Brooijmans |
Blueprint Medicines |
1 |
| #402 |
Silvia Buonamici |
Eisai R&D Management Co. |
1 |
| #402 |
David Brean |
Oracle |
1 |
| #402 |
Xun Han |
Adaptive 3D Technologies |
1 |
| #402 |
Akash Baid |
Microsoft |
1 |
| #402 |
Taylor A. Apgar |
Symbotic |
1 |
| #402 |
Waseem Asghar |
Brigham and Women's Hospital |
1 |
| #402 |
Taylor J. Castagna |
Waters Technologies |
1 |
| #402 |
Joshua Muller |
Puma Se |
1 |
| #402 |
Benjamin Harwood |
On Target Therapeutics |
1 |
| #402 |
Theodore R. MELLORS |
Scipher Medicine |
1 |
| #402 |
Manuel A. Navia |
Vertex Pharmaceuticals Incorporated |
1 |
| #402 |
Ronald G. Tompkins |
The General Hospital |
1 |
| #402 |
Ida Lister |
— |
1 |
| #402 |
Ionita Ghiran |
Beth Israel Deaconess Medical Center |
1 |
| #402 |
Elise E. Drouin |
The General Hospital |
1 |
| #402 |
Julian Guzman |
Nike |
1 |